CMS Targets Leadless Pacers For Medicare Coverage Analysis
This article was originally published in Clinica
The Medicare agency signaled that it plans to establish a national coverage policy for leadless pacemakers in a memo issued May 18. The memo comes about one month after FDA approved the first such product, Medtronic’s Micra transcatheter leadless single-chamber pacemaker.
Register for our free email digests: